CSF-tau levels correlated with [18F]flortaucipir (Figure 5a) retention in brain at early stages of AD, and also in presymptomatic patients, especially in the neocortex and parahippocampal gyrus [142,145,146]. The gene discussed is MAPT; the disease is Alzheimer disease.